Klinische studies myelodysplastisch syndroom (MDS)

Onbehandelde patiënten

GLORA-4 (APG2575MG301)

A Global Multicenter, Double-Blind, Randomized, Registrational  Phase 3 Study of Lisaftoclax (APG-2575) in Combination with Azacitidine (AZA) in Patients with Newly Diagnosed Higher Risk Myelodysplastic Syndrome (HR-MDS)

• Principal investigator: prof. dr. Mariëlle Beckers
• More information: NCT06641414
• Internal reference number: S70060

TAK-226-3001 

A Phase 3, Multicenter, Open-Label, Randomized Trial to Compare the Efficacy and Safety of Elritercept versus Epoetin Alfa for the Treatment of Anemia Due to IPSS-R Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes in ESA-naïve Adult Participants Who Require Red Blood Cell Transfusions

• Principal investigator: Prof. Dr. Mariëlle Beckers
• More information: NCT07422480
• Internal reference number: S71581

Behandelde patiënten

95804306EDI1001

A Phase 1, First-in-human, Dose Escalation Study of JNJ-95804306 for Relapsed or Refractory Hematological Malignancies

• Principal investigator: Prof. Dr. Mariëlle Beckers
• More information: NCT07572006
• Internal reference number: S71895